PanGen Biotech Inc Net Asset Quality Index
PanGen Biotech Inc net asset quality index. PanGen Biotech Inc (222110) has a Net Asset Quality Index of 91.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩32.76 Billion minus total liabilities of ₩2.74 Billion yields net assets of ₩30.03 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 222110 net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of PanGen Biotech Inc (2014–2024)
Net asset quality index of PanGen Biotech Inc from 2014 to 2024. This chart shows how PanGen Biotech Inc's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 91.6%, representing net assets of ₩30.03 Billion against total assets of ₩32.76 Billion KRW. Check 222110 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
PanGen Biotech Inc Net Asset Quality Index by Year (2014–2024)
PanGen Biotech Inc net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for PanGen Biotech Inc from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of PanGen Biotech Inc.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 81.5% | ₩24.91 Billion | ₩30.54 Billion | ₩5.64 Billion | ▲ +21.0 pp |
| 2023 | 60.6% | ₩12.57 Billion | ₩20.74 Billion | ₩8.18 Billion | ▼ -22.7 pp |
| 2022 | 83.3% | ₩17.22 Billion | ₩20.67 Billion | ₩3.45 Billion | ▲ +34.5 pp |
| 2021 | 48.8% | ₩21.10 Billion | ₩43.28 Billion | ₩22.18 Billion | ▲ +9.6 pp |
| 2020 | 39.1% | ₩14.21 Billion | ₩36.31 Billion | ₩22.10 Billion | ▼ -8.0 pp |
| 2019 | 47.1% | ₩18.43 Billion | ₩39.08 Billion | ₩20.66 Billion | ▼ -11.9 pp |
| 2018 | 59.1% | ₩26.94 Billion | ₩45.61 Billion | ₩18.67 Billion | ▼ -28.9 pp |
| 2017 | 88.0% | ₩31.31 Billion | ₩35.59 Billion | ₩4.28 Billion | ▼ -6.4 pp |
| 2016 | 94.4% | ₩35.31 Billion | ₩37.40 Billion | ₩2.09 Billion | ▲ +53.1 pp |
| 2015 | 41.3% | ₩6.56 Billion | ₩15.90 Billion | ₩9.34 Billion | ▼ -22.1 pp |
| 2014 | 63.3% | ₩10.69 Billion | ₩16.87 Billion | ₩6.18 Billion | — |